Anagnostics Presents Multiplexed Drugs of Abuse and Sepsis Test at Medica 2009

10 Nov 2009
Sarah Sarah
Marketing / Sales

Product news

Anagnostics Bioanalysis is to presents itself and its products for the first time during MEDICA. They will be presenting fully automated microarray technology and corresponding multiplex tests for clinical molecular diagnostics. Visit hall 17, booth D20 to find out more.

Drugs of Abuse test for analysis of immediate consumption
Anagnostics' researchers work on a Drugs of Abuse Test, based on Antibodies. The test is based on saliva samples to obtain results of proximate drug abuse.

'Our innovation is based on a quick and sensitive detection of drug consumption. As little as 1ng drug per ml saliva are sufficient for a positive result', explains Dr. Bernhard Ronacher, CSO of Anagnostics Bioanalysis GmbH. The test is currently validated by experts.

Sepsis test for rapid detection of pathogens
The second product shortly before validation is a test for rapid detection of pathogens based on DNA. This sepsis test is aimed to identify a wide spectrum of pathogens and its antibiotic resistances within 3 hours. Based on this information physicians can apply targeted therapy soon after first symptoms.

Fully automated tests
Anagnostics' hybcell technology is based upon the use of two cylinders. Detector molecules are immobilized on the surface of the inner cylinder in a microarray format, this inner cylinder is placed into a transparent cylindrical container. Both parts closely fit together and represent the core of the hybcell. Liquid sample is filled into the hybcell via the axial (central) channel with the help of a pipette. The cartridge is closed with a rubber lid. The cartridge is transferred to the device (hyborg).

From now on the device takes over and processes the hybcell in a fully automated manner. The results are summarized in compact reports. 'Anagnostics' hyborg can be loaded with 8, respectively 96 hybcells, which are processed fully automated and without user interaction. Usage of the software is simple and intuitive. Therefore the whole system is perfectly suited for clinical diagnostics' continues Ronacher.

Links

Tags

Microarray AnalysisMicroarrays, also known as biochips, are used for the detection and analysis of multiple genes, proteins, antibodies, or biomarkers on a single microchip. This can reveal information on protein or gene expression, single nucleotide polymorphism (SNP), copy number variation (CNV), epigenetics and patient health in clinical diagnostic tests. Discover a range of microarray scanners and prefabricated antibody, protein, RNA and DNA microarrays for your analysis or consider creating your own custom microarrays with a microarray printer. Find the best microarray products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.